Skip to main navigation Skip to search Skip to main content

Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology

  • Gregory J. Riely
  • , Douglas E. Wood
  • , David S. Ettinger
  • , Dara L. Aisner
  • , Wallace Akerley
  • , Jessica R. Bauman
  • , Ankit Bharat
  • , Debora S. Bruno
  • , Joe Y. Chang
  • , Lucian R. Chirieac
  • , Malcolm DeCamp
  • , Aakash P. Desai
  • , Thomas J. Dilling
  • , Jonathan Dowell
  • , Gregory A. Durm
  • , Scott Gettinger
  • , Travis E. Grotz
  • , Matthew A. Gubens
  • , Aditya Juloori
  • , Rudy P. Lackner
  • Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Dawn Owen, Dwight H. Owen, Sandip P. Patel, Tejas Patil, Patricio M. Polanco, Jonathan Riess, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Lisa Hang
  • Memorial Sloan-Kettering Cancer Center
  • Fred Hutchinson Cancer Research Center
  • Johns Hopkins University
  • University of Colorado Anschutz Medical Campus
  • University of Utah
  • Northwestern University
  • Cleveland Clinic Foundation
  • University of Texas MD Anderson Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center
  • University of Wisconsin-Madison
  • O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham
  • University of South Florida
  • UT Southwestern Simmons Comprehensive Cancer Center
  • Indiana University Bloomington
  • Yale University
  • Mayo Clinic
  • University of California at San Francisco
  • UChicago Medicine Comprehensive Cancer Center
  • University of Nebraska Medical Center
  • Mass General Cancer Center
  • University of Michigan, Ann Arbor
  • Stanford University
  • Vanderbilt University
  • City of Hope National Medical Center
  • University of Washington
  • Duke University
  • University of Tennessee Health Science Center
  • Ohio State University
  • University of California at San Diego
  • University of California at Davis
  • University of Pennsylvania
  • University of California at Los Angeles
  • National Comprehensive Cancer Network

Research output: Contribution to journalArticlepeer-review

547 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC, including diagnosis, primary disease management, surveillance for relapse, and subsequent treatment. The panel has updated the list of recommended targeted therapies based on recent FDA approvals and clinical data. This selection from the NCCN Guidelines for NSCLC focuses on treatment recommendations for advanced or metastatic NSCLC with actionable molecular biomarkers.

Original languageEnglish
Pages (from-to)249-274
Number of pages26
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume22
Issue number4
DOIs
StatePublished - May 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Biomarkers, Tumor/genetics
  • Carcinoma, Non-Small-Cell Lung/therapy
  • Humans
  • Lung Neoplasms/diagnosis
  • Molecular Targeted Therapy/methods
  • Neoplasm Staging

Fingerprint

Dive into the research topics of 'Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology'. Together they form a unique fingerprint.

Cite this